MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 137 filers reported holding MERSANA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $0 | – | 0 | – | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| Q1 2022 | $3,178,000 | -35.8% | 796,458 | 0.0% | 2.20% | -31.6% |
| Q4 2021 | $4,954,000 | -34.0% | 796,458 | 0.0% | 3.22% | -23.2% |
| Q3 2021 | $7,511,000 | -30.6% | 796,458 | 0.0% | 4.19% | +322.9% |
| Q2 2021 | $10,816,000 | -16.1% | 796,458 | 0.0% | 0.99% | -20.1% |
| Q1 2021 | $12,887,000 | -39.2% | 796,458 | 0.0% | 1.24% | -88.9% |
| Q4 2020 | $21,194,000 | +42.9% | 796,458 | 0.0% | 11.15% | -9.7% |
| Q3 2020 | $14,830,000 | -20.4% | 796,458 | 0.0% | 12.35% | +2.3% |
| Q2 2020 | $18,637,000 | +301.4% | 796,458 | 0.0% | 12.07% | +158.0% |
| Q1 2020 | $4,643,000 | +1.7% | 796,458 | 0.0% | 4.68% | +34.9% |
| Q4 2019 | $4,564,000 | +262.8% | 796,458 | 0.0% | 3.47% | +229.4% |
| Q3 2019 | $1,258,000 | -61.0% | 796,458 | 0.0% | 1.05% | -52.9% |
| Q2 2019 | $3,226,000 | -23.0% | 796,458 | 0.0% | 2.24% | -49.5% |
| Q1 2019 | $4,189,000 | +28.9% | 796,458 | 0.0% | 4.43% | -7.0% |
| Q4 2018 | $3,250,000 | -59.2% | 796,458 | 0.0% | 4.77% | -34.9% |
| Q3 2018 | $7,965,000 | -44.0% | 796,458 | 0.0% | 7.33% | -46.2% |
| Q2 2018 | $14,225,000 | +13.3% | 796,458 | 0.0% | 13.61% | -23.2% |
| Q1 2018 | $12,560,000 | -6.5% | 796,458 | -2.6% | 17.71% | -24.2% |
| Q4 2017 | $13,440,000 | -5.0% | 818,033 | 0.0% | 23.36% | +4.9% |
| Q3 2017 | $14,144,000 | +23.8% | 818,033 | 0.0% | 22.27% | +39.6% |
| Q2 2017 | $11,428,000 | – | 818,033 | – | 15.96% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 796,458 | $14,830,000 | 12.35% |
| Consonance Capital Management LP | 3,468,171 | $64,577,000 | 7.87% |
| Sarissa Capital Management LP | 2,837,000 | $52,824,000 | 6.22% |
| Bain Capital Life Sciences Investors, LLC | 3,445,667 | $64,158,000 | 5.98% |
| Ghost Tree Capital, LLC | 1,050,000 | $19,551,000 | 5.65% |
| NEA Management Company, LLC | 5,959,520 | $110,966,000 | 4.70% |
| Soleus Capital Management, L.P. | 393,041 | $7,318,000 | 3.88% |
| ACUTA CAPITAL PARTNERS, LLC | 667,500 | $12,429,000 | 3.38% |
| Avoro Capital Advisors LLC | 6,800,000 | $126,616,000 | 1.80% |
| FNY Investment Advisers, LLC | 199,800 | $3,720,000 | 1.57% |